Liver scan to predict complications before treatment
Part of Cancer, Digestive system clinical trials.
This study tests a special scan to predict complications before liver tumor treatment. It aims to help doctors plan safer surgery or ablation by checking how well your liver will handle the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and able to make your own medical decisions.
- You have one or more liver tumors, or a suspected liver tumor, and your medical team has recommended a local treatment like surgery or ablation.
- If you are having a major liver resection (removing a large part of the liver), you qualify.
- If you are having a minor liver resection or ablation, you must have at least one risk factor for poor liver function, such as cirrhosis, fibrosis, prior chemotherapy, or a chronic liver disease (like hepatitis B or C).
- You cannot have an allergy to technetium-99m or albumin, and you cannot have pulmonary hypertension or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well special imaging scans (PET/CT or PET/MRI) work in adults with suspected or diagnosed liver cancer. It may help doctors better see the cancer and plan next steps.
This trial uses special CT scans to create a map of your liver's blood vessels before surgery. The goal is to predict if your liver might fail after part of it is removed, so doctors can better plan your care.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
This study uses a special MRI scan to measure liver stiffness before surgery to remove liver tumors. The goal is to see if this scan can help predict surgical risks and improve outcomes for patients undergoing liver surgery.
This study looks at whether special scans can help doctors better predict how aggressive a person's liver cancer (hepatocellular carcinoma) will be, especially right after surgery. If you are planning to have surgery to remove the tumor as your first treatment, this trial might be a good fit.
This study checks how accurately a special scan (GSA) measures how well the remaining part of your liver works after surgery for liver, bile duct, or gallbladder disease. It aims to improve how doctors predict recovery and plan care after the operation.
Hear when a new Hepatic Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.